VIDEO: Waiting for long-term data on pCR could be disservice to some breast cancer patients, expert says

SAN FRANCISCO – Only a fraction of patients with breast cancer who are eligible for neoadjuvant therapy are getting it, partly because of confusion around the significance of achieving a pathologic...